Literature DB >> 12850541

Expression of voltage-gated potassium channels Kv1.3 and Kv1.5 in human gliomas.

Katja Preussat1, Christian Beetz, Michael Schrey, Robert Kraft, Stefan Wölfl, Rolf Kalff, Stephan Patt.   

Abstract

K(+) channels play an important role in glial cell proliferation and are functionally expressed in glial tumors. Because voltage-gated K(+) channel (Kv) subtypes Kv1.3 and Kv1.5 have been shown to contribute to growth-related properties of normal glia rather specifically, we investigated different human glioma samples for the expression of these channel subtypes using reverse transcriptase-PCR. Kv1.5 expression correlated with glioma entities and malignancy grades, i.e. expression was high in astrocytomas, moderate in oligodendrogliomas, and low in glioblastomas. No such correlation was evident for Kv1.3 expression. This study shows a clear differential expression of Kv1.5 in gliomas according to subtype and malignancy grade. This result corresponds to previous data on the expression of voltage-gated sodium channels in gliomas, which likewise showed a low or absent expression of channel subtypes in high-grade tumors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12850541     DOI: 10.1016/s0304-3940(03)00562-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  33 in total

1.  Deletion and mutation of WWOX exons 6-8 in human non-small cell lung cancer.

Authors:  Yulong Zhou; Yongjian Xu; Zhenxiang Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Reduced Kv1.3 potassium channel expression in human prostate cancer.

Authors:  Mansoor Abdul; Naseema Hoosein
Journal:  J Membr Biol       Date:  2007-06-02       Impact factor: 1.843

Review 3.  Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.

Authors:  Špela Gubič; Louise A Hendrickx; Žan Toplak; Maša Sterle; Steve Peigneur; Tihomir Tomašič; Luis A Pardo; Jan Tytgat; Anamarija Zega; Lucija P Mašič
Journal:  Med Res Rev       Date:  2021-05-01       Impact factor: 12.944

4.  Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenografts.

Authors:  Gary C Davis; Yali Kong; Mikell Paige; Zhang Li; Ellen C Merrick; Todd Hansen; Simeng Suy; Kan Wang; Sivanesan Dakshanamurthy; Antoinette Cordova; Owen B McManus; Brande S Williams; Maksymilian Chruszcz; Wladek Minor; Manoj K Patel; Milton L Brown
Journal:  Bioorg Med Chem       Date:  2011-09-01       Impact factor: 3.641

5.  Genistein inhibits the activity of kv1.3 potassium channels in human T lymphocytes.

Authors:  A Teisseyre; K Michalak
Journal:  J Membr Biol       Date:  2005-05       Impact factor: 1.843

6.  Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro.

Authors:  Wei-Xi Wang; Yong-Hua Ji
Journal:  J Neurooncol       Date:  2005-05       Impact factor: 4.130

7.  Kv1.1-dependent control of hippocampal neuron number as revealed by mosaic analysis with double markers.

Authors:  Shi-Bing Yang; Kellan D Mclemore; Bosiljka Tasic; Liqun Luo; Yuh Nung Jan; Lily Yeh Jan
Journal:  J Physiol       Date:  2012-03-12       Impact factor: 5.182

8.  Promoter Methylation Analysis Reveals That KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation.

Authors:  Katherine E Ryland; Allegra G Hawkins; Daniel J Weisenberger; Vasu Punj; Scott C Borinstein; Peter W Laird; Jeffrey R Martens; Elizabeth R Lawlor
Journal:  Mol Cancer Res       Date:  2015-11-16       Impact factor: 5.852

Review 9.  Roles of K+ channels in regulating tumour cell proliferation and apoptosis.

Authors:  Zhiguo Wang
Journal:  Pflugers Arch       Date:  2004-03-27       Impact factor: 3.657

10.  Expression of KCNA5 Protein in Human Mammary Epithelial Cell Line Associated with Caveolin-1.

Authors:  Jia Liu; Chao Qu; Hongyan Li; Yejun Zhang; Jia Sun; Shuo Yang; Jing Liu; Lijia An; Wei Zou
Journal:  J Membr Biol       Date:  2016-04-13       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.